Trial Identifier: | D1690R00044 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03549754 |
Start Date: | February 2018 |
Primary Completion Date: | December 2025 |
Study Completion Date: | December 2025 |
Condition: | Chronic Kidney Diseases; Congestive Heart Failure; Hypertension; Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Costa Rica, Los Yoses, San Pedro | San Jose, Los Yoses, San Pedro, Costa Rica, 11501 |
Egypt, Alexandria | Fleming, Alexandria, Egypt, NA |
Egypt, Assiut | downtown, Assiut, Egypt, NA |
Egypt, Cairo | Haram, Cairo, Egypt, NA |
India | Delhi, India, 110063 |
India | Pondicherry, India, 605014 |
India | Vadodara, India, 390023 |
India, Gujarat | Ahmedabad, Gujarat, India, 380015 |
India, Haryana | Rohtak, Haryana, India, 124514 |
India, Karnataka | Bangalore, Karnataka, India, 560010 |
India, Maharashtra | Pune, Maharashtra, India, 411001 |
India, Royapuram | Chennai, Royapuram, India, 600013 |
India, West Bengal | Kolkata, West Bengal, India, 700098 |
Malaysia, Iskandar Puteri | Johor Darul Takzim, Iskandar Puteri, Malaysia, 79250 |
Mexico, Chihuahua | Chihuahua, Mexico, 31217 |
Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44670 |
Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44340 |
Mexico, Jalisco | Guadalajara, Jalisco, Mexico, 44600 |
Mexico, Nuevo Leon | Monterrey, Nuevo Leon, Mexico, 64460 |
Mexico, Queretaro | San Juan del Rio, Queretaro, Mexico, 76800 |